the aid library

LIST OPTIONS

Filter

5562

Developing drinking-water quality regulations and standards: general guidance with a special focus on countries with limited resources

World Health Organization (WHO) (2018) CC

Drinking-water quality regulations and standards developed or revised in accordance with this guidance will reflect the best practices identified in the WHO Guidelines for Drinking-water Quality to most effectively protect public health. Moreover, the regulations and standards will consider local ne... more

External Link

Africa CDC Event-based Surveillance Resources

Africa Center for Disease Control and Prevention (2023) CC

The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing event-based surveillance (EBS) using a multisectoral, One Health approach. To ... more

Download (300)

View PDF (397)

Case Study: Community Engagement and Accountability

Myanmar Red Cross Society (2016) C1

Integrating community engagement and accountability into disaster risk reduction activities of the Maternal, Newborn and Child Healthcare programme in rural Myanmar

Download (332)

View PDF (312)

Speaking Out - Toolkit for MSM-Led HIV/AIDS Advocacy

J. Ripley; K. Lauer; C. Leopold The Global Forum on MSM and HIV (MSMGF) (2013) C2

Download (341)

View PDF (332)

CH 5: Effective strategies for detecting maltreatment of children and youth within the context of mental health and developmental assessment.

World Health Organization (2015) C_WHO

(New 2015) Scoping question: Within the context of mental health and developmental assessment of children and youth, what are the effective strategies for detecting maltreatment?

Download (990)

View PDF (2670)

Communication and social mobilization in yellow fever mass vaccination campaigns

World Health Organization WHO (2015) C_WHO

10 points from field experience

Download (641)

View PDF (942)

Strengthening the Role of Women with Disabilities in Humanitarian Action: A Facilitator’s Guide

B. Lee, E. Pearce, D. Buscher Women’s Refugee Commission (2017) C1

Download (460)

View PDF (668)

Access to Services and Barriers faced by People with Disabilities: A Quantitative Survey

Nathan Grills, Lawrence Singh, Hira Pant, Jubin Varghese, GVS Murthy, Monsurul Hoq, Manjula Marella Disability, CBR & Inclusive Development Journal (DCIDJ) (2017) CC

In low- and middle-income middle-income countries, reliable and disaggregated disability data on prevalence, participation and barriers are often unavailable. This study aimed to estimate disability prevalence, determine associated socio-demographic factors and compare access in the community betwee... more

Download (454)

View PDF (601)

Toolkit for the Integration of Mental Health into General Healthcare in Humanitarian Settings

International Medical Corps (2019) C1

This Toolkit aims to support the understanding and implementation of integrated mental health programs in humanitarian settings. It provides a framework for essential steps and components, with associated key guidance and resources, that strengthen the integration process, and is primarily intended ... more

Download (563)

View PDF (741)

Integrated care for older people (‎ICOPE)‎: guidance for person-centred assessment and pathways in primary care
recommended

World Health Organization WHO (2019) C_WHO

The ICOPE guidance for person-centred assessment and pathways in primary care (ICOPE Handbook) helps community health and care workers put the recommendations outlined in the ICOPE Guidelines into practice. The Handbook assists with setting person-centred goals, screening for loss in a range of doma... more

External Link

Out of the dark: Meeting the needs of children with TB

Médecins sans Frontières (2011) C3

Download (332)

View PDF (403)

COVID-19 Risk Communications and Community Engagement (RCCE) and the Humanitarian System: Briefing Pack

Inter-Agency Standing Committee IASC (2020) C1

This briefing pack serves this purpose by sharing RCCE/humanitarian coordination experience from country level, feedback from global consultations and addressing frequently asked questions. In parallel, the RCCE Core Group has been working to revise the RCCE Collective Service Strategy. Where possib... more

Download (256)

View PDF (366)

A step-by-step Guide to develop National Action Plans for Noma Prevention and Control in Priority Countries

World Health Organisation (WHO) (2020) C_WHO

Noma (cancrum oris) is a severe gangrenous disease of the mouth and face. It mostly affects children between the ages of 2 and 6 years living in extreme poverty. In addition to the known factors such as malnutrition, lack of vaccination in children and poor oral hygiene, several social and environme... more

Download (297)

View PDF (424)

Practice Guidelines for Treating Gambling-Related Problems

Korn, D.A. and H.J. Shaffer (2004) CC

An Evidence-Based Treatment Guide for Clinicians

Download (367)

View PDF (453)

Global vaccine safety blueprint 2.0 (GVSB2.0) 2021-2023

World Health Organization WHO (2022) C_WHO

Download (253)

View PDF (240)

The Global State of Harm Reduction 2016

K. Stone; G. Sander Harm Reduction International (2016) C2

External Link

Environmental Determinants of Cardiovascular Disease

Bhatnagar, A. Circulation Research (2018) CC

Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu... more

Download (460)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (446)

View PDF (699)

India: TRAINING OF Link ART Centre (LAC) COUNSELLORS - HANDBOOK FOR TRAINEES

National AIDS Control Organization (NACO), Ministry of Health and Family Welfare, Government of India (2012) C1

Download (595)

View PDF (415)

Nursing Skills and Procedures - Pocket Guide

Anne Griffin, Patricia A. Potter Elsevir (2015) CC

Mosby’s Pocket Guide to Nursing Skills and Procedures, eighth edition, is a practical, portable reference for students and practitioners in the clinical setting. Grouped alphabetically, 85 commonly performed skills are presented in a clear, step-by-step format that includes: ■ Purpose for pe... more

Integrated care for older people (‎ICOPE)‎: guidance for person-centred assessment and pathways in primary care recommended

Integrated care for older people (‎ICOPE)‎: guidance for person-centred assessment and pathways in primary care
recommended